Significant Achievements and Future Outlook for MYSPHERA and PATHMAKER
One of the most remarkable achievements is the reduction of deployment times by 50%. This substantial decrease will allow MYSPHERA to streamline its operations, delivering projects faster and more efficiently. This improvement is critical in the healthcare sector, where timely implementation of patient flow solutions can significantly impact overall hospital operations and patient care.
The scalability of MYSPHERA is significantly boosted, enabling the company to handle twice as many projects with the same number of staff. This increase in scalability is a testament to the efficiency and robustness of the PATHMAKER project. Additionally, the flexibility of MYSPHERA has been demonstrated through PATHMAKER's ability to design projects for three distinct use cases: surgical blocks, emergency departments, and endoscopy units. This versatility ensures that MYSPHERA can meet a wide range of healthcare needs, making it a valuable asset for various medical environments.
PATHMAKER is hailed as the most powerful solution for designing and deploying real-time patient flow projects in a graphical and collaborative way. The introduction of a new Demand Planner Designer optimizes surgical block capacity by up to 15%, enhancing operational efficiency. The new Real-Time Location System based on Angle of Arrival (AoA) technology offers precision below the meter, providing highly accurate location tracking. Additionally, a new AI functional block enables descriptive analytics, paving the way for advanced data-driven decision-making and operational improvements.
PATHMAKER's Intellectual Property Rights (IPR) have been filed, paving the way for a strategic go-to-market approach. This move is crucial for protecting the innovative aspects of PATHMAKER and ensuring its competitive edge in the market. MYSPHERA has also increased its awareness and positioning in the patient flow market through an aggressive marketing campaign. This campaign includes more than 35 significant actions, both online and physical, and a smart inbound strategy. Such comprehensive marketing efforts have raised the profile of MYSPHERA and positioned it as a leader in the industry.
The performance and effectiveness of MYSPHERA have been documented in two published papers, providing evidence of its capabilities and benefits. The published papers can be accessed through the following links:
-
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538689/(s’ouvre dans une nouvelle fenêtre)-
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345239/(s’ouvre dans une nouvelle fenêtre)Furthermore, PATHMAKER has received notable accolades, including an award at the European Healthcare Design Congress 2023 and being a finalist in the Value-Based Healthcare Prize 2024. These recognitions underscore the innovation and impact of the PATHMAKER project in the healthcare industry.
MYSPHERA is now poised to approach the second venture capital round with the support of the European Innovation Council (EIC). This financial backing will enable further development and expansion. Forecasts predict sales of 40 million euros by 2028, highlighting the significant market potential and growth prospects for MYSPHERA and PATHMAKER.
In summary, thanks to PATHMAKER, MYSPHERA has successfully reduced deployment times, enhanced scalability and flexibility, and secured intellectual property rights. The company has strengthened its market position through a robust marketing campaign and gained academic recognition through published performance evidence. With upcoming financial support and promising sales forecasts, MYSPHERA is well-positioned for continued growth and innovation in the healthcare industry. The technological advancements in PATHMAKER, including enhanced location accuracy and AI capabilities, ensure that MYSPHERA remains at the forefront of real-time patient flow solutions.
